Kaiser Permanente has announced that the company has collaborated with the Civica Rx to improve the affordability and availability of essential generic medicines during the recent Covid-19 pandemic outbreak.
The company has further added that it joins the Civica Rx as a governing member on the Board of Directors, which is an integrated health system and has 12.4 million members. The recent collaboration of Kaiser Permanente with Civica Rx comes at a time, when the Civica Rx is already delivering necessary generic medications to treat the Covid-19 patients.
Civica Rx was founded by the leading healthcare systems of the United States with the aim to overcome the shortages of essential generic drugs among patients.
Kaiser Permanente has said that it has a deep commitment to reduce the barriers and drug prices of essential generic medications. The company has administered 54 million patients and over 90 million prescriptions annually.
Chairman and Chief Executive Officer of Kaiser Permanente, Greg Adams said, “At Kaiser Permanente, we know that our members and all Americans need access to affordable medications for emergency care and to support recovery from illness and management of chronic conditions.”
“The COVID-19 pandemic has put a spotlight on the critical need for ensuring consistent supplies of affordable, generic medications for patients and we are proud to join with Civica Rx to help lead these efforts,” Greg Adams further added.
Chief Executive Officer of Civica RX, Martin VanTrieste said, “Kaiser Permanente is one of the country’s most respected health organizations and we are honored they are joining Civica at a moment when the U.S. and the world are grappling with this public health emergency and uncertainty about a second wave for COVID-19.”
“We will greatly value their expertise and input on the board during this urgent time of need,” Civica Rx CEO Martin VanTrisete concluded.